These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1725233)
1. Modified-live infectious bovine rhinotracheitis virus (IBRV) vaccine expressing foot-and-mouth disease virus (FMDV) capsid protein epitopes on surface of hybrid virus particles. Kit S; Kit M; DiMarchi R; Little S; Gale C Adv Exp Med Biol; 1991; 303():211-20. PubMed ID: 1725233 [No Abstract] [Full Text] [Related]
2. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles. Kit S; Kit M; DiMarchi RD; Little SP; Gale C Arch Virol; 1991; 120(1-2):1-17. PubMed ID: 1718244 [TBL] [Abstract][Full Text] [Related]
3. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes. Kit M; Kit S; Little SP; Di Marchi RD; Gale C Vaccine; 1991 Aug; 9(8):564-72. PubMed ID: 1722936 [TBL] [Abstract][Full Text] [Related]
4. Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72. Suryanarayana VV; Venkataramanan R; Rao BU; Padayatty JD Biochem Int; 1992 May; 26(6):1003-16. PubMed ID: 1378734 [TBL] [Abstract][Full Text] [Related]
5. Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins. Sanz-Parra A; V Zquez B; Sobrino F; Cox SJ; Ley V; Salt JS J Gen Virol; 1999 Mar; 80 ( Pt 3)():671-679. PubMed ID: 10092007 [TBL] [Abstract][Full Text] [Related]
6. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology. Brown F Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918 [No Abstract] [Full Text] [Related]
8. Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus. Almeida MR; Rieder E; Chinsangaram J; Ward G; Beard C; Grubman MJ; Mason PW Virus Res; 1998 May; 55(1):49-60. PubMed ID: 9712511 [TBL] [Abstract][Full Text] [Related]
9. Use of peptides for immunization against foot-and-mouth disease. Brown F Vaccine; 1988 Apr; 6(2):180-2. PubMed ID: 2838987 [TBL] [Abstract][Full Text] [Related]
10. Antigenic structure of foot and mouth disease virus type A22 (Indian isolates). Tulasiram P; Suryanarayana V Indian J Exp Biol; 1998 Jan; 36(1):70-5. PubMed ID: 9536655 [TBL] [Abstract][Full Text] [Related]
11. Construction of a recombinant BHV-1 expressing the VP1 gene of foot and mouth disease virus and its immunogenicity in a rabbit model. Ren XG; Xue F; Zhu YM; Tong GZ; Wang YH; Feng JK; Shi HF; Gao YR Biotechnol Lett; 2009 Aug; 31(8):1159-65. PubMed ID: 19343503 [TBL] [Abstract][Full Text] [Related]
12. Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain. González M; Mateu MG; Martínez MA; Carrillo C; Sobrino F Vaccine; 1992; 10(11):731-4. PubMed ID: 1279905 [TBL] [Abstract][Full Text] [Related]
14. Investigation of possible vaccine-induced epizootics of infectious bovine rhinotracheitis, using restriction endonuclease analysis of viral DNA. Whetstone CA; Wheeler JG; Reed DE Am J Vet Res; 1986 Aug; 47(8):1789-95. PubMed ID: 3019192 [TBL] [Abstract][Full Text] [Related]
16. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example. Vol'pina OM; Surovoi AYu ; Ivanov VT Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462 [TBL] [Abstract][Full Text] [Related]
17. [Viral vaccines produced by gene technology and synthesis]. Hess RG Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142 [TBL] [Abstract][Full Text] [Related]
18. The serological response to foot-and-mouth disease vaccination is not affected by simultaneous infectious bovine rhinotracheitis/adenovirus/parainfluenza 3 vaccination. de Clercq K; Strobbe R; van Opdenbosch E; Wellemans G; Theys H; Debecq J Arch Exp Veterinarmed; 1989 May; 43(3):409-13. PubMed ID: 2549906 [TBL] [Abstract][Full Text] [Related]
19. [Primary structure of the gene for protein VP1 from foot-and-mouth disease virus serotype O1 isolated in the USSR]. Onishchenko AM; Petrov NA; Mamaeva NV; Kalashnikova TI; Grinev AA; Sosnovtsev SV; Degtiarev SKh; Karpyshev NN; Perevozchikova NA; Ivaniushchenkov Vn Mol Gen Mikrobiol Virusol; 1990 Apr; (4):22-5. PubMed ID: 1694961 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunization. Shieh JJ; Liang CM; Chen CY; Lee F; Jong MH; Lai SS; Liang SM Vaccine; 2001 Jul; 19(28-29):4002-10. PubMed ID: 11427276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]